2025 Q3 -tulosraportti
47 päivää sittenTarjoustasot
Nasdaq Copenhagen
Määrä
Osto
69 594
Myynti
Määrä
71 653
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| 1 207 | - | - | ||
| 1 062 | - | - | ||
| 25 | - | - | ||
| 222 | - | - | ||
| 31 | - | - |
Ylin
192VWAP
Alin
189,05VaihtoMäärä
44,9 235 025
VWAP
Ylin
192Alin
189,05VaihtoMäärä
44,9 235 025
Välittäjätilasto
Dataa ei löytynyt
Yhtiötapahtumat
| Seuraava tapahtuma | |
|---|---|
| 2025 Q4 -tulosraportti | 12.3.2026 |
| Menneet tapahtumat | ||
|---|---|---|
| 2025 Q3 -tulosraportti | 14.11. | |
| 2025 Q2 -tulosraportti | 22.8. | |
| 2025 Q1 -tulosraportti | 9.5. | |
| 2024 Q4 -tulosraportti | 5.3. | |
| 2024 Q3 -tulosraportti | 15.11.2024 |
Datan lähde: FactSet
Asiakkaat katsoivat myös
Shareville
Liity keskusteluun SharevillessäShareville on aktiivisten yksityissijoittajien yhteisö, jossa voit seurata muiden asiakkaiden kaupankäyntiä ja omistuksia.
Kirjaudu
·20 t sittenIt may well be that Bavarian is the second most sold-off, but it is also the most speculated, which is partly due to reckless trading and dealing with the stock. Product sales have been steadily increasing, and the real value is apparently estimated at over 250. Who then has an interest in selling off and currently keeping it below 190. One should rather try to address that!
·1 päivä sittenHeadline of article in Medwatch: The Bavarian Nordic share is the second most sold off in 2025 After two private equity funds made a takeover bid, investors began to flee from the Danish vaccine company, according to Nordnet.
·19 t sittenDivestments can, e.g., be due to investors selling in the market in connection with takeover attempts. That wouldn't have been so bad after all.
·22.12.Bavarian has started to look a bit stronger in recent days. Could well see Bavarian moving up towards 200 before the end of the year. Several so-called “experts” believe in rising prices for Bavarian in 2026. But many of those “experts” predict erratically, so be careful.·1 päivä sittenYes, which experts were also involved and wanted to sell at 250?
·19.12.It's good that, in a time of crisis for the company, the board is just working on incentive programs for themselves.... Oh well.·22.12.one cannot know what the board will subsequently get up to. However, I don't think one should underestimate that all complaining has an effect, no matter where it comes from. It does create some small waves. I have a small position now and sold everything at the top. But I would have bought back more, if I didn't perceive the board as hopeless·22.12.Also very difficult to change for small investors - and it's probably quite normal that bonuses are given if the set goals are achieved - what the amount should be is probably the big question.
·16.12.There is still no official status on when Serum Institute of India (SII) will begin production of Bavarian Nordic's mpox vaccine in India: The technology transfer agreement was concluded in December 2024 Bavarian Nordic IR manager Disa Tuominen will not answer the question and would not raise the question at the investor meeting even though we had submitted it.
·20.12.It takes a long time to transfer that kind of thing. Bava bought a series of travel vaccines in 2019 and apparently only brought production home here in 2025. It can, of course, be that it can go faster here, but expect it to take a long time unless it has very high priority with both the company and the authorities, as the Covid vaccines did. But bava can keep up with demand now, so it's probably limited what it will mean to complete the transfer.
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Sharevillen käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Uutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
2025 Q3 -tulosraportti
47 päivää sittenUutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Shareville
Liity keskusteluun SharevillessäShareville on aktiivisten yksityissijoittajien yhteisö, jossa voit seurata muiden asiakkaiden kaupankäyntiä ja omistuksia.
Kirjaudu
- ·20 t sittenIt may well be that Bavarian is the second most sold-off, but it is also the most speculated, which is partly due to reckless trading and dealing with the stock. Product sales have been steadily increasing, and the real value is apparently estimated at over 250. Who then has an interest in selling off and currently keeping it below 190. One should rather try to address that!
- ·1 päivä sittenHeadline of article in Medwatch: The Bavarian Nordic share is the second most sold off in 2025 After two private equity funds made a takeover bid, investors began to flee from the Danish vaccine company, according to Nordnet.·19 t sittenDivestments can, e.g., be due to investors selling in the market in connection with takeover attempts. That wouldn't have been so bad after all.
- ·22.12.Bavarian has started to look a bit stronger in recent days. Could well see Bavarian moving up towards 200 before the end of the year. Several so-called “experts” believe in rising prices for Bavarian in 2026. But many of those “experts” predict erratically, so be careful.·1 päivä sittenYes, which experts were also involved and wanted to sell at 250?
- ·19.12.It's good that, in a time of crisis for the company, the board is just working on incentive programs for themselves.... Oh well.·22.12.one cannot know what the board will subsequently get up to. However, I don't think one should underestimate that all complaining has an effect, no matter where it comes from. It does create some small waves. I have a small position now and sold everything at the top. But I would have bought back more, if I didn't perceive the board as hopeless·22.12.Also very difficult to change for small investors - and it's probably quite normal that bonuses are given if the set goals are achieved - what the amount should be is probably the big question.
- ·16.12.There is still no official status on when Serum Institute of India (SII) will begin production of Bavarian Nordic's mpox vaccine in India: The technology transfer agreement was concluded in December 2024 Bavarian Nordic IR manager Disa Tuominen will not answer the question and would not raise the question at the investor meeting even though we had submitted it.·20.12.It takes a long time to transfer that kind of thing. Bava bought a series of travel vaccines in 2019 and apparently only brought production home here in 2025. It can, of course, be that it can go faster here, but expect it to take a long time unless it has very high priority with both the company and the authorities, as the Covid vaccines did. But bava can keep up with demand now, so it's probably limited what it will mean to complete the transfer.
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Sharevillen käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
Nasdaq Copenhagen
Määrä
Osto
69 594
Myynti
Määrä
71 653
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| 1 207 | - | - | ||
| 1 062 | - | - | ||
| 25 | - | - | ||
| 222 | - | - | ||
| 31 | - | - |
Ylin
192VWAP
Alin
189,05VaihtoMäärä
44,9 235 025
VWAP
Ylin
192Alin
189,05VaihtoMäärä
44,9 235 025
Välittäjätilasto
Dataa ei löytynyt
Asiakkaat katsoivat myös
Yhtiötapahtumat
| Seuraava tapahtuma | |
|---|---|
| 2025 Q4 -tulosraportti | 12.3.2026 |
| Menneet tapahtumat | ||
|---|---|---|
| 2025 Q3 -tulosraportti | 14.11. | |
| 2025 Q2 -tulosraportti | 22.8. | |
| 2025 Q1 -tulosraportti | 9.5. | |
| 2024 Q4 -tulosraportti | 5.3. | |
| 2024 Q3 -tulosraportti | 15.11.2024 |
Datan lähde: FactSet
2025 Q3 -tulosraportti
47 päivää sittenUutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Yhtiötapahtumat
| Seuraava tapahtuma | |
|---|---|
| 2025 Q4 -tulosraportti | 12.3.2026 |
| Menneet tapahtumat | ||
|---|---|---|
| 2025 Q3 -tulosraportti | 14.11. | |
| 2025 Q2 -tulosraportti | 22.8. | |
| 2025 Q1 -tulosraportti | 9.5. | |
| 2024 Q4 -tulosraportti | 5.3. | |
| 2024 Q3 -tulosraportti | 15.11.2024 |
Datan lähde: FactSet
Shareville
Liity keskusteluun SharevillessäShareville on aktiivisten yksityissijoittajien yhteisö, jossa voit seurata muiden asiakkaiden kaupankäyntiä ja omistuksia.
Kirjaudu
- ·20 t sittenIt may well be that Bavarian is the second most sold-off, but it is also the most speculated, which is partly due to reckless trading and dealing with the stock. Product sales have been steadily increasing, and the real value is apparently estimated at over 250. Who then has an interest in selling off and currently keeping it below 190. One should rather try to address that!
- ·1 päivä sittenHeadline of article in Medwatch: The Bavarian Nordic share is the second most sold off in 2025 After two private equity funds made a takeover bid, investors began to flee from the Danish vaccine company, according to Nordnet.·19 t sittenDivestments can, e.g., be due to investors selling in the market in connection with takeover attempts. That wouldn't have been so bad after all.
- ·22.12.Bavarian has started to look a bit stronger in recent days. Could well see Bavarian moving up towards 200 before the end of the year. Several so-called “experts” believe in rising prices for Bavarian in 2026. But many of those “experts” predict erratically, so be careful.·1 päivä sittenYes, which experts were also involved and wanted to sell at 250?
- ·19.12.It's good that, in a time of crisis for the company, the board is just working on incentive programs for themselves.... Oh well.·22.12.one cannot know what the board will subsequently get up to. However, I don't think one should underestimate that all complaining has an effect, no matter where it comes from. It does create some small waves. I have a small position now and sold everything at the top. But I would have bought back more, if I didn't perceive the board as hopeless·22.12.Also very difficult to change for small investors - and it's probably quite normal that bonuses are given if the set goals are achieved - what the amount should be is probably the big question.
- ·16.12.There is still no official status on when Serum Institute of India (SII) will begin production of Bavarian Nordic's mpox vaccine in India: The technology transfer agreement was concluded in December 2024 Bavarian Nordic IR manager Disa Tuominen will not answer the question and would not raise the question at the investor meeting even though we had submitted it.·20.12.It takes a long time to transfer that kind of thing. Bava bought a series of travel vaccines in 2019 and apparently only brought production home here in 2025. It can, of course, be that it can go faster here, but expect it to take a long time unless it has very high priority with both the company and the authorities, as the Covid vaccines did. But bava can keep up with demand now, so it's probably limited what it will mean to complete the transfer.
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Sharevillen käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
Nasdaq Copenhagen
Määrä
Osto
69 594
Myynti
Määrä
71 653
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| 1 207 | - | - | ||
| 1 062 | - | - | ||
| 25 | - | - | ||
| 222 | - | - | ||
| 31 | - | - |
Ylin
192VWAP
Alin
189,05VaihtoMäärä
44,9 235 025
VWAP
Ylin
192Alin
189,05VaihtoMäärä
44,9 235 025
Välittäjätilasto
Dataa ei löytynyt